379 related articles for article (PubMed ID: 33349909)
1. Systemic cell therapy for muscular dystrophies : The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy.
Ausems CRM; van Engelen BGM; van Bokhoven H; Wansink DG
Stem Cell Rev Rep; 2021 Jun; 17(3):878-899. PubMed ID: 33349909
[TBL] [Abstract][Full Text] [Related]
2. Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies.
Motohashi N; Shimizu-Motohashi Y; Roberts TC; Aoki Y
Cells; 2019 Sep; 8(9):. PubMed ID: 31514443
[TBL] [Abstract][Full Text] [Related]
3. Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients.
Skuk D; Tremblay JP
Expert Opin Biol Ther; 2015; 15(9):1307-19. PubMed ID: 26076715
[TBL] [Abstract][Full Text] [Related]
4. Myoblast transfer therapy: is there any light at the end of the tunnel?
Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
6. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
7. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.
Salani S; Donadoni C; Rizzo F; Bresolin N; Comi GP; Corti S
J Cell Mol Med; 2012 Jul; 16(7):1353-64. PubMed ID: 22129481
[TBL] [Abstract][Full Text] [Related]
8. Current advances in cell therapy strategies for muscular dystrophies.
Negroni E; Vallese D; Vilquin JT; Butler-Browne G; Mouly V; Trollet C
Expert Opin Biol Ther; 2011 Feb; 11(2):157-76. PubMed ID: 21219234
[TBL] [Abstract][Full Text] [Related]
9. Stem cell therapy for muscular dystrophies.
Biressi S; Filareto A; Rando TA
J Clin Invest; 2020 Nov; 130(11):5652-5664. PubMed ID: 32946430
[TBL] [Abstract][Full Text] [Related]
10. Pericytes in Skeletal Muscle.
Gautam J; Yao Y
Adv Exp Med Biol; 2019; 1122():59-72. PubMed ID: 30937863
[TBL] [Abstract][Full Text] [Related]
11. Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.
Klimczak A; Kozlowska U; Kurpisz M
Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):341-354. PubMed ID: 29536116
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.
Selvaraj S; Kyba M; Perlingeiro RCR
Trends Mol Med; 2019 Sep; 25(9):803-816. PubMed ID: 31473142
[TBL] [Abstract][Full Text] [Related]
13. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation for muscular dystrophy: the challenge of immune response.
Maffioletti SM; Noviello M; English K; Tedesco FS
Biomed Res Int; 2014; 2014():964010. PubMed ID: 25054157
[TBL] [Abstract][Full Text] [Related]
15. Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes.
Negroni E; Bigot A; Butler-Browne GS; Trollet C; Mouly V
Hum Gene Ther; 2016 Feb; 27(2):117-26. PubMed ID: 26652770
[TBL] [Abstract][Full Text] [Related]
16. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.
Tedesco FS; Dellavalle A; Diaz-Manera J; Messina G; Cossu G
J Clin Invest; 2010 Jan; 120(1):11-9. PubMed ID: 20051632
[TBL] [Abstract][Full Text] [Related]
17. The role of stem cells in muscular dystrophies.
Meregalli M; Farini A; Colleoni F; Cassinelli L; Torrente Y
Curr Gene Ther; 2012 Jun; 12(3):192-205. PubMed ID: 22463740
[TBL] [Abstract][Full Text] [Related]
18. Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.
Berry SE
Stem Cells Transl Med; 2015 Jan; 4(1):91-8. PubMed ID: 25391645
[TBL] [Abstract][Full Text] [Related]
19. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
20. Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice.
Meng J; Chun S; Asfahani R; Lochmüller H; Muntoni F; Morgan J
Mol Ther; 2014 May; 22(5):1008-17. PubMed ID: 24569833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
